Inspire Medical price target raised to $305 from $300 at Piper Sandler
The Fly

Inspire Medical price target raised to $305 from $300 at Piper Sandler

Piper Sandler analyst Adam Maeder raised the firm’s price target on Inspire Medical to $305 from $300 and keeps an Overweight rating on the shares. The company reported Q4 results with sales at the high-end of the preannouncement and earnings materially better than forecasts, the analyst tells investors in a research note. Piper says Inspire "brings substantial momentum into the new year" and it continues to view the stock as its favorite name in 2023.

Published first on TheFly

See today’s best-performing stocks on TipRanks >>

Read More on INSP:

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App